PL2394648T3 - Kompozycja farmaceutyczna do podawania doustnego - Google Patents

Kompozycja farmaceutyczna do podawania doustnego

Info

Publication number
PL2394648T3
PL2394648T3 PL10738504.9T PL10738504T PL2394648T3 PL 2394648 T3 PL2394648 T3 PL 2394648T3 PL 10738504 T PL10738504 T PL 10738504T PL 2394648 T3 PL2394648 T3 PL 2394648T3
Authority
PL
Poland
Prior art keywords
pharmaceutical composition
oral administration
oral
administration
pharmaceutical
Prior art date
Application number
PL10738504.9T
Other languages
English (en)
Inventor
Takehiko Yasuji
Noriyuki Kinoshita
Hiroyuki Yoshino
Shuuya Kawahama
Kazuhiro Sako
Akio Sugihara
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42542065&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2394648(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of PL2394648T3 publication Critical patent/PL2394648T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/439Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom the ring forming part of a bridged ring system, e.g. quinuclidine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/16Amides, e.g. hydroxamic acids
    • A61K31/18Sulfonamides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841Filling excipients; Inactive ingredients
    • A61K9/4866Organic macromolecular compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/08Drugs for disorders of the urinary system of the prostate

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Urology & Nephrology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL10738504.9T 2009-02-04 2010-02-02 Kompozycja farmaceutyczna do podawania doustnego PL2394648T3 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14985409P 2009-02-04 2009-02-04

Publications (1)

Publication Number Publication Date
PL2394648T3 true PL2394648T3 (pl) 2016-12-30

Family

ID=42542065

Family Applications (1)

Application Number Title Priority Date Filing Date
PL10738504.9T PL2394648T3 (pl) 2009-02-04 2010-02-02 Kompozycja farmaceutyczna do podawania doustnego

Country Status (27)

Country Link
US (1) US9198904B2 (pl)
EP (1) EP2394648B1 (pl)
JP (1) JP5553026B2 (pl)
KR (1) KR20110126650A (pl)
CN (1) CN102307579B (pl)
AU (1) AU2010211725C1 (pl)
BR (1) BRPI1007484B1 (pl)
CA (1) CA2751039C (pl)
CY (1) CY1118057T1 (pl)
DK (1) DK2394648T3 (pl)
ES (1) ES2603747T3 (pl)
HR (1) HRP20161138T1 (pl)
HU (1) HUE029638T2 (pl)
IL (1) IL214420A (pl)
LT (1) LT2394648T (pl)
MX (1) MX342062B (pl)
MY (1) MY160652A (pl)
NZ (1) NZ594311A (pl)
PL (1) PL2394648T3 (pl)
PT (1) PT2394648T (pl)
RS (1) RS55151B1 (pl)
RU (1) RU2580652C2 (pl)
SG (1) SG173528A1 (pl)
SI (1) SI2394648T1 (pl)
UA (1) UA102885C2 (pl)
WO (1) WO2010090172A1 (pl)
ZA (1) ZA201105572B (pl)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5028893B2 (ja) 2006-07-18 2012-09-19 日産自動車株式会社 アンダーカバー
TWI519322B (zh) * 2008-04-15 2016-02-01 愛戴爾製藥股份有限公司 包含弱鹼性藥物及控制釋放劑型之組合物
EP2500013B1 (en) * 2011-03-15 2019-10-02 Alfred E. Tiefenbacher (GmbH & Co. KG) Pharmaceutical composition comprising solifenacin
CN102743757A (zh) * 2012-07-09 2012-10-24 张家华 治疗膀胱流出道梗阻所致膀胱活动过度的药物
CN104602693A (zh) * 2012-08-31 2015-05-06 安斯泰来制药株式会社 口服给药用药物组合物
KR101639692B1 (ko) * 2013-12-13 2016-07-14 제일약품주식회사 2 이상의 유효성분을 포함하는 구강 내 속붕해 다중유닛 약제학적 조성물
JP2017078023A (ja) * 2014-02-28 2017-04-27 アステラス製薬株式会社 経口投与用医薬組成物
JP6915258B2 (ja) * 2016-10-21 2021-08-04 ニプロ株式会社 医薬組成物粒子とそれを含む口腔内崩壊製剤、医薬組成物粒子の製造方法
EP3697392B1 (en) 2017-10-17 2023-11-15 Synthon B.V. Tablets comprising tamsulosin and solifenacin
MX2022013103A (es) * 2020-04-27 2022-11-30 Zim Laboratories Ltd Nueva composicion farmaceutica multiparticulada de tamsulosina y solifenacina.
EP4255398A1 (en) 2020-12-01 2023-10-11 Adamed Pharma S.A. Orally-administered preparation containing solifenacin and tamsulosin

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS56110665A (en) * 1980-02-08 1981-09-01 Yamanouchi Pharmaceut Co Ltd Sulfamoyl-substituted phenetylamine derivative and its preparation
US5391825A (en) * 1980-02-08 1995-02-21 Yamanouchi Pharmaceutical Co., Ltd. Sulfamoyl substituted phenethylamine intermediates
US4558156A (en) * 1980-02-08 1985-12-10 Yamanouchi Pharmaceutical Co., Ltd. Sulfamoyl-substituted phenethylamine derivatives
EP0185117A1 (de) 1984-12-21 1986-06-25 IPEX Getränke-Herstellungs- und Vertriebsgesellschaft mbH Getränk
JPS62114952A (ja) 1985-11-13 1987-05-26 Yamanouchi Pharmaceut Co Ltd 置換フエネチルアミン誘導体の製造法
DK0661045T3 (da) 1992-09-18 2002-10-28 Yamanouchi Pharma Co Ltd Hydrogelpræparat med forsinket frigivelse
NO2005012I1 (no) * 1994-12-28 2005-06-06 Debio Rech Pharma Sa Triptorelin og farmasoytisk akseptable salter derav
US6878386B1 (en) * 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
GB0129962D0 (en) * 2001-12-14 2002-02-06 Pfizer Ltd Method of treatment
EA007156B1 (ru) * 2002-04-15 2006-08-25 Адамс Лэборетриз, Инк. Замедленно высвобождающие лекарственные композиции гвайфенезина
CN100355419C (zh) * 2002-06-07 2007-12-19 安斯泰来制药有限公司 治疗膀胱过度活动的药物
JP4523265B2 (ja) * 2002-11-13 2010-08-11 旭化成ファーマ株式会社 排尿障害治療用口腔内崩壊製剤
US7442387B2 (en) * 2003-03-06 2008-10-28 Astellas Pharma Inc. Pharmaceutical composition for controlled release of active substances and manufacturing method thereof
US8128958B2 (en) * 2003-11-10 2012-03-06 Astellas Pharma Inc. Sustained release pharmaceutical composition
US8197846B2 (en) 2003-11-10 2012-06-12 Astellas Pharma Inc. Sustained release pharmaceutical composition
CA2550983C (en) * 2003-12-24 2013-09-17 Advancis Pharmaceutical Corporation Enhanced absorption of modified release dosage forms
US20080103171A1 (en) * 2004-12-27 2008-05-01 Astellas Pharma Inc. Stable Particular Pharmaceutical Composition of Solifenacin or Salt Thereof
CA2599158C (en) * 2005-02-25 2011-01-25 Astellas Pharma Inc. Pharmaceutical agent comprising solifenacin
US7815939B2 (en) * 2005-07-20 2010-10-19 Astellas Pharma Inc. Coated fine particles containing drug for intrabuccally fast disintegrating dosage forms
CA2697137A1 (en) * 2007-07-20 2009-01-29 Astellas Pharma Inc. Pharmaceutical composition for amelioration of lower urinary tract symptoms associated with prostatomegaly
EP2018850A1 (en) * 2007-07-24 2009-01-28 Ratiopharm GmbH Pharmaceutical composition comprising solifenacin or a pharmaceutically acceptable salt thereof

Also Published As

Publication number Publication date
IL214420A (en) 2016-09-29
EP2394648B1 (en) 2016-08-31
NZ594311A (en) 2013-05-31
MY160652A (en) 2017-03-15
IL214420A0 (en) 2011-09-27
SI2394648T1 (sl) 2017-02-28
KR20110126650A (ko) 2011-11-23
CY1118057T1 (el) 2017-06-28
EP2394648A1 (en) 2011-12-14
LT2394648T (lt) 2016-10-10
BRPI1007484A2 (pt) 2016-02-16
WO2010090172A1 (ja) 2010-08-12
CN102307579B (zh) 2013-10-16
ES2603747T3 (es) 2017-03-01
US20100233260A1 (en) 2010-09-16
JP5553026B2 (ja) 2014-07-16
HRP20161138T1 (hr) 2016-11-04
DK2394648T3 (en) 2016-09-26
SG173528A1 (en) 2011-09-29
BRPI1007484B1 (pt) 2019-04-16
MX342062B (es) 2016-09-12
PT2394648T (pt) 2016-10-03
AU2010211725B2 (en) 2014-04-10
HUE029638T2 (en) 2017-03-28
RS55151B1 (sr) 2017-01-31
CN102307579A (zh) 2012-01-04
JPWO2010090172A1 (ja) 2012-08-09
RU2580652C2 (ru) 2016-04-10
US9198904B2 (en) 2015-12-01
AU2010211725A1 (en) 2011-08-25
CA2751039C (en) 2015-05-05
CA2751039A1 (en) 2010-08-12
EP2394648A4 (en) 2012-08-29
MX2011008188A (es) 2011-09-29
UA102885C2 (ru) 2013-08-27
ZA201105572B (en) 2012-09-26
RU2011136636A (ru) 2013-03-10
AU2010211725C1 (en) 2014-10-16

Similar Documents

Publication Publication Date Title
IL218928A (en) Corticosteroids for oral administration
HK1164059A1 (en) Compositions for drug administration
ZA201101523B (en) Linaclotide-containing formulations for oral administration
ZA201105572B (en) Pharmaceutical composition for oral administration
HK1160034A1 (zh) 用於吸入的藥用組合物
EP2591773A4 (en) TEMPORARY RELEASED PHARMACEUTICAL COMPOSITION WITH DAPOXIN FOR ORAL ADMINISTRATION
EP2629786A4 (en) COMPOSITIONS FOR THE ADMINISTRATION OF MEDICAMENTS
ZA201100615B (en) Appetising medicament for oral administration in solid form
EP2226071A4 (en) COMPOSITIONS FOR ORAL ADMINISTRATION
IL221742A (en) Oral Pharmaceuticals Containing Debigtran Etxylate
EP2263637A4 (en) MEDICINAL PREPARATION FOR ORAL ADMINISTRATION
IL219617A0 (en) Pharmaceutical solid dosage form
EP2206519A4 (en) MEDICINAL PREPARATION FOR ORAL ADMINISTRATION
EP2407162A4 (en) COMPOSITION FOR ORAL ADMINISTRATION
PL2253326T3 (pl) Kompozycja farmaceutyczna do podawania przeznosowego
EP2520300A4 (en) PHARMACEUTICAL COMPOSITION FOR ORAL ADMINISTRATION
ZA201102405B (en) Pharmaceutical composition for oral administration
HU0900482D0 (en) Pharmaceutical formulation for oral administration
EP2474294A4 (en) PREPARATION FOR ORAL ADMINISTRATION
EP2529755A4 (en) PHARMACEUTICAL COMPOSITION AND PREPARATION THEREFOR FOR ORAL ADMINISTRATION
EP2473168A4 (en) PHARMACEUTICAL FORMULATIONS FOR INDIBULIN
PT2519261E (pt) Composição farmacêutica líquida oral de nifedipina
GB0906003D0 (en) Oral drug formulation